Currently housed in the Massachusetts Medical Device Development Center (M2D2) Incubator (a JLab facility) in Lowell MA, Articulate Biosciences LLC, is a Boston University spin-out structured around developing injectable viscoelastic gels designed for the treatment of arthritis and other soft tissue diseases. The company's gel utilizes tissue-protecting and function-restoring biomedical polymers designed to help in eliminating chronic joint pain - enabling patients suffering from osteoarthritis to get relieve from pain and restore mobility. Completely different from existing supplements, the firm's synthetic, non-hyaluronic-acid polymer is designed to last significantly longer within the joint than previously available products. Designated Ultravisc, the product injects viscous fluids into osteoarthritic joints - an injectable medical device that resides within the joints for six months as the product lubricates, cushions, and protects the damaged area.
